|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets | |||||||
| Cash, cash equivalents and restricted cash | |||||||
| Accounts receivable, net of allowance for credit losses of $0.1 million | |||||||
| Inventory | |||||||
| Prepaid expenses and other current assets | |||||||
| Total current assets | |||||||
| Property and equipment, net | |||||||
| Capitalized software, net | |||||||
| Other assets | |||||||
| Total assets | |||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| LIABILITIES | |||||||
| Current liabilities | |||||||
| Accounts payable | |||||||
| Accrued expenses and other current liabilities | |||||||
| Convertible debt | |||||||
| Other current debt | |||||||
| Current accrued interest | |||||||
| Deferred revenue, current portion | |||||||
| Total current liabilities | |||||||
| Series P and P-2 Preferred Stock liability | |||||||
| Convertible debt, noncurrent | |||||||
| Other noncurrent debt | |||||||
| Noncurrent accrued interest | |||||||
| Deferred revenue, net of current portion | |||||||
| Total liabilities | |||||||
| Stockholders' deficit: | |||||||
| Common stock, $0.00001 par value; 100,000,000 shares authorized as of September 30, 2026; 37,068,058 and 1,294,142 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |||||||
| Additional paid-in capital | |||||||
| Accumulated other comprehensive income | |||||||
| Accumulated deficit | |||||||
| Total stockholders' deficit | |||||||
| Total liabilities and stockholders' deficit |
Loading...